BioCentury
ARTICLE | Company News

Lotus Tissue Repair, Shire deal

January 14, 2013 8:00 AM UTC

Shire will acquire Lotus Tissue Repair for an undisclosed upfront payment, plus milestones. Shire will gain Lotus Tissue's lead product, a preclinical recombinant form of human collagen Type VII (rC7...